Skip to main content
SpringerLink
Log in

Proceedings of the American Society of Pediatric Nephrology 1994 Educational Symposium, Seattle, WA., 1, 2 May, 1994

  • Occasional Survey
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. O'Meara YM, Natori Y, Minto AWM, Goldstein DJ, Manning EC, Salant DJ (1992) Nephrotoxic antiserum identifies a β1-intergrin on rat glomerular epithelial cells. Am J. Physiol 363: F1083-F1091

    Google Scholar 

  2. Mendrick DL, Kelly DM (1993) Temporal expression of VLA-2 and modulation of its ligand specificity by rat glomerular epithelial cells in vitro. Lab Invest 69:690–702

    Google Scholar 

  3. Gautheir VJ, Mannik M (1990) A small proportion of cationic antibodies in immune complexes is sufficient to mediate their deposition. J Immunol 145:3348–3552

    Google Scholar 

  4. Groggel GC, Adler S, Rennke HG, Couser WG, Salant DJ (1983) Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest 72:1948–1957

    Google Scholar 

  5. Savin VJ, Johnson RJ, Couser WG (1990) Antibody induced complement activation increases albumin permeability of isolated rat glomeruli. Kidney Int 37:430

    Google Scholar 

  6. Abrass CK (1986) Evaluation of sequential glomerular eluates from rats with Heymann nephritis. J Immunol 137:530–536

    Google Scholar 

  7. Orikasa M, Matsui K, Oite T, Shimizu F (1988) Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 141:807–814

    Google Scholar 

  8. Savin VJ (1993) Mechanisms of proteinuria in noninflammatory glomerular disease. Am J Kidney Dis 21:347–362

    Google Scholar 

  9. Mene P, Simonson MS, Dunn MJ (1989) Physiology of the mesangial cell. Physiol Rev 69:1347–1428

    Google Scholar 

  10. Johnson RJ, Iida H, Alpers CE, Majesk MW, Schwartz SM, Pritzl P, Gordon K, Gown AM (1991) Expession of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87:847–858

    Google Scholar 

  11. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG (1991) Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477–488

    Google Scholar 

  12. Johnson RJ, Pritzl P, Iida H, Alpers CE (1990) Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313–321

    Google Scholar 

  13. Johnson RJ, Garcia RL, Pritzl P, Alpers CE (1990) Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136:369–374

    Google Scholar 

  14. Floege J, Eng E, Lindner V, Alpers CE, Young BA, Reidy MA, Johnson RJ (1992) Rat glomerular mesangial cells synthesize basic FGF: release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90: 2362–2369

    Google Scholar 

  15. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ (1993) Infusion of PDGF or basic FGF induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952–2962

    Google Scholar 

  16. Iida H, Seifert R, Alpers CE, Grownwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ (1991) Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:6560–6564

    Google Scholar 

  17. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers CE, Ross R (1992) Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to plateler-derived growth factor. J Exp Med 175:1413–1416

    Google Scholar 

  18. Border WA, Okuda S, Languino LR, Sporn MB, Rusolahti E (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346: 371–374

    Google Scholar 

  19. Border WA, Noble NA, Yamamoto T, Yamaguchi Y, Pierschbacher MD, Rusolahti E (1992) Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361–364

    Google Scholar 

  20. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM (1992) Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464–474

    Google Scholar 

  21. Raines EW, Lane TF, Iruela-Arispe M, Ross R, Sage EH (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and-BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89:1281–1285

    Google Scholar 

  22. Lovett DH, Johnson RJ, Marti H-P, Martin J, Davies M, Couser WG (1992) Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141: 85–98

    Google Scholar 

  23. Fajardo LF (1989) The complexity of endothelial cells. Am J Clin Pathol 92:241–250

    Google Scholar 

  24. Ballermann BJ (1989) Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 256:C182-C189

    Google Scholar 

  25. Tonshoff B, Momper R, Kuhl PG, Schweer H, Scharer K, Seyberth HW (1990) Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney Int 37:1134–1141

    Google Scholar 

  26. Monnens L, Bakker WW (1994) Coagulation and renal disease. In: Holliday MA, Barratt TM, Avner ED (eds) Pediatric nephrology, 3rd edn. Williams and Wilkins, Baltimore, pp 822–835

    Google Scholar 

  27. Savage COS (1994) The biology of the glomerulus: endothelial cells. Kidney Int 45:314–319

    Google Scholar 

  28. Cotran RS, Pober JS (1989) Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 35:969–975

    Google Scholar 

  29. Brady HR, Spertini O, Jimenez W, Brenner BM, Marsden PA, Teddler TF (1992) Neutrophils, monocytes, and lymphocytes bind to cytokine-activated kidney glomerular endothelial cells throughl-selectin (LAM-1) in vitro. J Immunol 149:2437–2444

    Google Scholar 

  30. Marsden PA, Brock TA, Ballermann BJ (1990) Glomerular endothelial cells respond to calcium-mobilizing agonists with releas of EDRF. Am J Physiol 258:F1295-F1303

    Google Scholar 

  31. Yamamoto C, Kaji T, Sakamoto M, Koizumi F (1992) Effect of endothelin on the release of tissue plasminogen activator and plasminogen activator inhibitor-1 from cultured human endothelial cells and interaction with thrombin. Thromb Res 67:619–624

    Google Scholar 

  32. McCarron RM, Wang L, Stanimirovic DB, Spatz M (1993) Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 156:31–34

    Google Scholar 

  33. Takeda M, Iwasaki S, Hellings SE, Yoshida H, Homma T, Kon V (1994) Divergent expression of Et A and Et B receptors in response to cyclosporine in mesangial cells. Am J Pathol 144: L473-L479

    Google Scholar 

  34. Iwasaki S, Homma T, Kon V (1994) Site selective modulation in the kidney of endothelin and its receptor subtypes by cyclosporine. Kidney Int 45:592–597

    Google Scholar 

  35. Iwasaki S, Homma T, Matsuda Y, Kon V, (1995) Endothelin icceptor subtype B mediates autoinduction of endothelin-1 production in rat mesangial cells. J. Biol Chem 270:6997–7003

    Google Scholar 

  36. Hudson BG, Reeders ST, Tryggvason K (1993) Type IV collagen: structure, gene organization, and role in human diseases. J Biol Chem 268:26033–26036

    Google Scholar 

  37. Kashtan CE, Michael AF (1993) Alport syndrome: from bedside to genome to bedside. Am J Kidney Dis 22:627–640

    Google Scholar 

  38. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AI, Gerken SC, Gregory MC, Skolnick MH, Atkin CL (1990) Identification of mutations in the COL45A5 collagen gene in Alport syndrome. Science 248:1224–1227

    Google Scholar 

  39. Ding J, Kashtan CE, Fan WW, Kleppel MM, Sun MJ, Kalluri R, Neilson EG, Michael AF (1994) A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the α5 chain of type IV collagen. Kidney Int 45:1504–1506

    Google Scholar 

  40. Mochizuki T, Mariyama M, Smeets HJM, Lemmink HH, Pirson Y, Verellen C, Antignac C, Gubler MC, Reeders ST (1993) Identification of mutations in the α3 and α4 type IV collagen genes in autosomal recessive Alport syndrome (abstract). J Am Soc Nephrol 4:819

    Google Scholar 

  41. Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takeshoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE (1995) Type IV collagen α5 chain: normal distribution and abnormallies in X-linked Alport syndrome revealed by monoclonal antibody Am J Pathol (in press)

  42. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, Paepe A de, Tryggvason K, Reeders ST (1993) Deletion of the paired α5 (IV) and α6 (IV) collagen genes in inherited smooth muscle tumors. Science 261:1167–1169

    Google Scholar 

  43. Greenspan DS, Byers MG, Eddy RL, Cheng W, Jani-Sait S, Shows TB (1992) Human collagen gene COL45A1 maps to the q34.2–q34.3 region of chromosome 9, near the locus for nailpatella syndrome. Genomics 12:836–837

    Google Scholar 

  44. Gubler MC, Dommergues JP, Foulard M, Bensman A, Leroy JP, Broyer M, Habib R (1993) Collagen type III glomerulopathy: a new type of hereditary nephropathy. Pediatr Nephrol 7:354–360

    Google Scholar 

  45. Kestila M, Mannikko M, Holberg C, Korpela K, Savolainen E-R, Peltonen L, Tryggvason K (1994) Exclusion of eight genes as mutated loci in congenital nephrotic syndrome of the Finnish type. Kidney Int 45:986–990

    Google Scholar 

  46. Ellis A (1942) Natural history of Bright's disease. Lancet I:1–7

    Google Scholar 

  47. Aubia J, Hojman L, Chine M (1987) Hypertension and nephrotoxicity in the rate of decline in kidney function in diabetic nephropathy. Clin Nephrol 27:15–20

    Google Scholar 

  48. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano Di Belgioioso G, Imbasciati E, Ragni A, Bertdi S, Fogazzi G, Duca G (1986) Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 59:363–378

    Google Scholar 

  49. Anderson S, Brenner BM (1990) The critical role of nephron mass and of intraglomerular pressure for initiation and progression of experimental hypertensive-renal disorders. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology diagnosis and management. Raven, New York, pp 1163–1176

    Google Scholar 

  50. Moore RA (1931) The total number of glomeruli in the normal human kidney. Anat Rec 48:153–168

    Google Scholar 

  51. Hayman JM Jr, Martin J Jr, Miller M (1939) Renal function and the number of glomeruli in the human kidney. Arch Intern Med 64:69–83

    Google Scholar 

  52. Brenner BM, Garcia DL, Anderson S (1990) The renal abnormality in hypertension: a proposed defect in glomerular filtration surface area. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology diagnosis and management. Raven, New York, pp 1151–1161

    Google Scholar 

  53. Barker DJP, Osmond C, Golding J, Kuh D, Wadsworth MEJ (1989) Growth in utero, blood pressure in childhood and adult life and mortality from cardiovascular disease. BMJ 298:564–567

    Google Scholar 

  54. Holland FJ, Stark D, Ades AE, Peckham CS (1993) Birth weight and body mass index in childhood, adolescence and adulthood as predictors of pressure at age 36. J Epidemiol Community Health 47:432–435

    Google Scholar 

  55. Royer P, Habib R, Leclerc F (1967) L'hypoplasie renale bilaterale avec oligomeganephronie. Proceedings of the 3rd International Congress on Nephrology, vol 2. Karger, Basel, pp 251–275

    Google Scholar 

  56. Kiprov DD, Colvin RB, McCluskey RT (1982) Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 46:275–281

    Google Scholar 

  57. Smith MC, Dunn MJ (1990) Hypertension in renal parenchymal disease. In: Laragh JH, Brenner BM (eds) Hypertension, pathophysiology diagnosis and management. Raven, New York, pp 1583–1599

    Google Scholar 

  58. Blythe WB (1985) Natural history of hypertension in renal parenchymal disease. Am J Kidney Dis 5:A50-A56

    Google Scholar 

  59. Orofino L, Quereda C, Lamas S (1987) Hypertension in primary chronic glomerulonephritis: analysis of 288 biopsied patients. Nephron 45:22–26

    Google Scholar 

  60. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584–594

    Google Scholar 

  61. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM (1981) Hyperfiltration in remnant nephrons. A potentially adverse response to renal ablation. Am J Physiol 241: F85-F93

    Google Scholar 

  62. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456–1462

    Google Scholar 

  63. O'Donnell MP, Schmitz PG (1991) Dietary and pharmacologic manipulations of lipids. Contemp Issues Nephrol 24:127–148

    Google Scholar 

  64. Kasiske BL, O'Connell MP, Cleary MP, Keane WF (1968) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667–672

    Google Scholar 

  65. Diamond JR (1991) The role of cholesterol in glomerular injury. Contemp Issues Nephrol 24:109–126

    Google Scholar 

  66. Wheeler DC, Chana RS (1993) Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 19: 149–164

    Google Scholar 

  67. Schoenholzer KW, Waldron M, Magil AB (1992) Intraglomerular foam cells and human focal glomerulosclerosis. Nephron 62: 130–136

    Google Scholar 

  68. Coritsidis G, Rifici V, Gupta S, Rie J, Zihe S, Neugarten J, Schlondorff D (1991) Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39:858–866

    Google Scholar 

  69. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924

    Google Scholar 

  70. Bank N (1993) Renal hemodynamic consequences of hyperlipidemia. Miner Electrolyte Metab 19:165–172

    Google Scholar 

  71. O'Donnel MP, Kasiske BL, Kim Y, Athuru D, Keane WF (1993) The mevalonate pathway: importance in mesangial cell biology and glomerular disease. Miner Electrolyte Metab 19:173–179

    Google Scholar 

  72. Hoeg JM (1991) Pharmagologic and surgical treatment of dyslipidemic children and adolescents. Ann N Y Acad Sci 623: 275–284

    Google Scholar 

  73. deleted

  74. Buerke M, Weyrich AS, Zheng A, Gaeta FCA, Forrest MJ, Lefer AM (1994) Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 93:1140–1148

    Google Scholar 

  75. Granert C, Raud J, Xie X, Lindquist L, Lindborn L (1994) Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. J Clin Invest 93:929–936

    Google Scholar 

  76. Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaki M, Kihara I (1993) Antibodies againt intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 150:1074–1083

    Google Scholar 

  77. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguch Y, Piersbacher MD, Ruoslahti E (1992) Natural inhibitor of transforming growth factor-β protects against scarring in expen mental kidney disease. Nature 360:361–364

    Google Scholar 

  78. Gesualdo L, Ricanati S, Hassan MO, Emancipator SN, Lamm ME (1990) Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest 86:715–722

    Google Scholar 

  79. Badr KF, Schriener GF, Wasserman M, Ichikawa I (1988) Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist. J Clin Invest 81:1702–1709

    Google Scholar 

  80. Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr S (1985) Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 82:193–197

    Google Scholar 

  81. Soifer NE, Van Why SK, Ganz M, Kashgarian M, Siegel NL, Stewart AF (1993) Expression of parathyroid hormone-related protein in the rat glomerulus and tubule during recovery from renal ischemia. J Clin Invest 92:2850–2857

    Google Scholar 

  82. Feng L, Tang WW, Loskutoff DJ, Wilson CB (1992) Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody nephritis. J Am Soc Nephrol 3: 1753–1764

    Google Scholar 

  83. Kruez W, Linde R, Becker S, Seifried E (1993) Successful treatment of haemolytic uremic syndrome with recombinant tissue-type plasminogen activator. Lancet 341:1665–1666

    Google Scholar 

  84. Bergstein J (1989) Tissue plasminogen activator therapy of glomerular thrombi in the Schwartzman reaction. Kidney Int 34: 14–18

    Google Scholar 

  85. Lovett DH, Johnson RJ, Marti H-P, Martin J, Davies M, Couser WG (1992) Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune-complex mediated glomerulonephritis. Am J Pathol 141: 85–98

    Google Scholar 

  86. Reckelhoff JF, Tygart VL, Mitias MM, Walcott JL (1993) STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats. Diabetes 42:1425–1432

    Google Scholar 

  87. Paczek L, Teschner M, Schaefer RM, Kovar J, Romen W, Heidland A (1992) Intraglomerular proteinase activity in Adriamycin-induced nephropathy. Nephron 60:81–86

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Wisconsin, 600 Highland Avenue, H4/458 CSC, 53792-4108, Madison, WI, USA

    Aaron Friedman (Editor)

Authors
  1. Aaron Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ben Brouhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shermine Dabbagh
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The American Society of Pediatric Nephrology (ASPN) is comprised of nephrologists in North America interested in the care of children and adolescents with kidney and urological diseases. The ASPN sponsors an annual educational symposium which is the major forum for the educational mission of the society. The following is a synopsis of the 1994 ASPN Educational Symposium.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedman, A., Brouhard, B. & Dabbagh, S. Proceedings of the American Society of Pediatric Nephrology 1994 Educational Symposium, Seattle, WA., 1, 2 May, 1994. Pediatr Nephrol 9, 526–536 (1995). https://doi.org/10.1007/BF00866745

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00866745

Keywords

Search

Navigation